Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer
SEATTLE, May 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTA: CTIC) today announced that that its Board of Directors has authorized a "Modified Dutch Auction" tender offer (the "Exchange Offer") and that it intends
to exchange shares of its common stoc...
CryoCath intends to contest patent infringement claim by CryoCor, Inc.
http://www.cryocath.com Toronto Stock Exchange Symbol: CYT
MONTREAL, Jan. 16 /PRNewswire-FirstCall/ - CryoCath(R) Technologies
Inc. (TSX: CYT), the global leader in cryotherapy products to treat
cardiovascular disease, today announced that CryoCor, Inc. has filed patent
Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
ROCKVILLE, Md., Nov. 2 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals
Inc. (Nasdaq: VNDA ) announced that, despite strong demand, it no longer
intends to offer convertible senior notes. The decision not to pursue a
convertible note offering at this time was due principally to prevailing
QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
LES ULIS, France, September 3 /PRNewswire-FirstCall/ -- - QUANTEL has Entered Into the Final Phase of the Negotiations in View
of Acquiring the Company WaveLight Aesthetic GmbH A strong complementarity This company, a subsidiary of the German company WaveLight AG, is
specialized in Dermatol...
Nuvo Announces 2009 second quarter financial results
...nd transdermal drug delivery technologies. Nuvo's lead product is Pennsaid, a topical NSAID used for the treatment of osteoarthritis of the knee. Nuvo intends
to leverage its skin-penetrating technologies to create a portfolio of topical and transdermal products targeting a variety of indications.
Nuvo is ...
Hard To Treat Diseases (HTDS) Chile Flu Vaccine Tender
...portunity related to Mellow Hope's MedVac flu vaccine products. The company intends
to participate in a formal tender process to supply a couple separate order...are multiple pending tenders in Chile.
In other Company news, the company intends
to release its Q2 financials on or before August 15th due date, shortly fol...
Allscripts Notified of Purported Class Action Lawsuit
The Company stated that it believes the allegations made in the complaint are without merit and that it intends
to vigorously defend against the complaint.
Allscripts uses innovation technology to bring health to healthcare. Mo...
Labopharm Reports Results for Second Quarter Fiscal 2009
...Novel Trazodone Formulation
Company to Submit Response to FDA - Following discussions with the U.S. Food and Drug Administration (FDA), Labopharm intends
to submit its response to the Agency next week. As previously disclosed, the Company received a complete response letter from the FDA indicating that ...
Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
...Group have substantially complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC. Watson intends
to cooperate fully with the FTC's review and continues to expect the transaction to close in the second half of 2009.
About Watson Pharmaceuti...
Chindex International, Inc. Launches World-Class Cancer Treatment Center
...l utilize established resources, such as
medical and surgical cancer treatment from BJU, a leading institution in
Beijing's medical community. Chindex intends
to host a formal ceremony to
celebrate the opening of the New Hope Center later in the year.
Roberta Lipson, President and CEO of Chindex, comm...
Intends in Medical Technology
AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
AMSTERDAM, October 3 /PRNewswire-FirstCall/ -- Amsterdam Molecular
Therapeutics (Euronext: AMT), a leader in the field of human gene therapy,
announced today that it intends
to incorporate additional data into the
Marketing Authorization Application (MAA) for Glybera(R) for Lipoprotein
Callisto Intends to Move Guanilib into Clinical Trials in
Announces Positive Data in Animal Models of Ulcerative Colitis
NEW YORK, April 05, 2007 /PRNewswire-FirstCall/ -- Callisto
Pharmaceuticals, Inc. , a developer of new drug treatments in the
fight against cancer and other major health threats, announced
today additional data confirming efficacy of G...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
...tion trials started in Korea as soon as reasonably possible."
to design all clinical studies of ProLindac in accordance with FDA standards and intends
to use the clinical data from all three planned clinical trials in the Far ...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
...in liquid cytology samples from cervical smears and tissue biopsy samples. The AttoSense test is currently available for Research Use Only. SEQUENOM intends
to seek FDA and EU approvals as soon as practical. SEQUENOM will continue to collaborate with major medical centers to further validate and demonstra...
Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
...ndary endpoints will also be evaluated.
NVA237 was licensed to Novartis in April 2005 by Sosei and its
co-development partner Vectura. Novartis intends
to launch NVA237 as a
once-daily monotherapy for COPD and also in combination with Novartis'
investigational once-daily, long-acting beta2-agonist (LA...
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
... ATPotent(TM) in the European Union (EU) as well as Russia and Ukraine. CTI intends
to initiate with Cordex's scientific support a proof-of-concept clinical tr... current expectations, estimates and projections made by management. Cordex intends
for the forward-looking statements to be covered by the safe harbor provisi...
CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
...ative disorders. The drug candidate, CXB909, is a small molecule, orally active agent that enhances the effects of nerve growth factor (NGF). CeNeRx intends
to initiate a Phase l trial of CXB909 for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) later this year.
"Nerve growth facto...
VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
...atherosclerotic cardiovascular disease. Guidance from the FDA will be incorporated into the VIA-2291 registration and Phase 3 program, and the company intends
to submit its proposed Phase 3 plan to FDA including a request for a Special Protocol Assessment. The Company is currently exploring strategic opportu...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
...oviding better lives and lower healthcare costs for our neighbors."
In addition to simplifying how vital sign data is collected, VivoMetrics also intends
to transform how healthcare professionals can utilize this data in caring for their remote patients. In partnership with OBS Medical (Carmel, IN), Viv...
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
...tient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and intends
to apply these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary, high-v...
Intends in Medical Dictionary
... A surrogate mother is the woman who is pregnant with the child and intends
to ... Presently, the idea of surrogate motherhood has gained some societal acceptance ... A surrogate key in a database is a unique identif...
... theory for information presented ... Eye Movement Desensitization and Reprocessing (EMDR) is a tool used in certain forms of psychotherapy that intends
to relieve the symptoms o... Desensitization is a two step process. ... Systematic desensitization is a very effective way to overcome phobias...
...ored yellow to make the easy to follow. ... The interscalene brachial plexus block has been performed for years for relief ... This web site intends
to provide support, promote public awareness and serve as an invaluable resource for Brachial Plexus Neuromas, Erb's Palsy Nerve Injuries and ... ...
Intends in Biological News
Stem cell research: From molecular physiology to therapeutic applications
...he mechanism of differentiation and de-differentiation, cellular plasticity and totipotency of pluripotent cells, as well as that of somatic cells. He intends
to build various cellular and animal models for human diseases, to uncover mechanisms underlying these different cellular processes and to discover ne...
Common allergy drug reduces obesity and diabetes in mice
...t thing about these drugs is that we know it's safe for people," says Shi. "The remaining question now is: Will this also work for people?"
Shi now intends
to test both cromolyn and ketotifen fumarate on obese and diabetic non-human primates.
Beyond friendly fire
In findings independent of Shi, ...
First cGMP feeder-independent pluripotent stem cell banks released for distribution
"The availability of stem cell banks that have been produced and tested under cGMP is a critical component of any program that intends
to advance a stem cell-based therapy into human clinical trials," says Erik Forsberg, executive director of WiCell. "Using matched research/cGMP stem ...
UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants
...th of healthy tissue our hope is that we can eliminate secondary surgeries," he said.
With $300,000 in funding from The Hartwell Foundation, Leach intends
to engineer a porous, biodegradable material with the mechanical properties of bone that can be placed along the sutures as a substitute for the fragm...
Scientists give a hand(edness) to the search for alien life
...ect the polarized reflections from the organisms chlorophyll from a short distance away. The device detected chirality from both sources.
The team intends
to improve its detector so it can look at pond surfaces and then landscape-sized regions on Earth. Provided the team continues to get good results, Ge...
MIT: How you feel the world impacts how you see it
...n of the visual cortex known as MT or V5 long thought to play a major role in the perception of motion may also process tactile motion. Moore's team intends
to explore this brain region in future studies to determine whether it contributes to these cross-modal motion aftereffects.
Global alliance of leading technological universities to address global societal issues
... The Alliance held its first meeting at NTU on 6 April 2009 and elected Dr Su as the first Chairman of the Alliance for a 2-year term.
The Alliance intends
to provide a collective academic and technological voice giving impetus to the international community to take action. The target groups include inter...
UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples
...picture quality, lower power consumption and a broad range of design flexibility. UniPixel licenses its TMOS technology to manufacturing partners and intends
to supply its Opcuity(TM) thin films to those manufacturers. UniPixel produces Opcuity(TM) FPR which serves as a high performance protective cover fi...
Two Hutchinson Center researchers named HHMI Early Career Scientists
...ition to cancer known as Fanconi anemia. Reactivation of the pathway, he discovered, can help tumors become resistant to chemotherapy drugs. Taniguchi intends
to dig deeper into this mechanism of drug resistance and use the information he uncovers to develop drugs that will re-sensitize tumors to cancer ther...
BIO-key to Respond in Court to a Lawsuit Filed by Two Investors
... terms and conditions of such preferred stock. The Company does not believe that it is in breach of any redemption obligations to these investors and intends
to defend itself against this claim vigorously. The Company also is evaluating potential counterclaims it may have in the lawsuit.
Intends in Biological Technology
MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission
ORCHARD PARK, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- MINRAD International,
Inc. (Amex: BUF ) -- On February 2, 2009, the Company received a notice from
NYSE Alternext US LLC (the "Exchange") stating that the Exchange intends
strike the common stock of the Company from the Exchange by fili...
Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
BASEL, Switzerland, Jan. 30 /PRNewswire/ -- Roche announced today that it intends
to commence a cash tender offer for all outstanding publicly-held shares of Genentech at US$ 86.50 per share. Roche, which currently owns 55.8% of the Genentech outstanding shares, expects to commence the tender offe...
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...e with Article II, Section 12 of the Company's By-Laws, requesting the Board to fix a record date for stockholder action by written consent, the Board intends
to set a record date as provided in the Company's By-Laws.
About KV Pharmaceutical Company
KV Pharmaceutical Company is a fully integrate...
ThermoGenesis Provides Update on Fiscal 2009 Results
...other prospective sites which, if successful, is expected to generate additional revenues.
Positive clinical response to the MXP. The Company intends
to add additional MXP distribution partners in fiscal 2010.
Launch of the Res-Q System. Res-Q is expected to add incremental revenues in 2010 th...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... States or Europe will grant regulatory approval based upon this data, in combination with the other efficacy and safety results the company currently intends
to submit in support of its NDA and MAA filings. Further analyses of the CAPACITY results will be conducted in the future and additional observations ...
Oncothyreon announces webcast of second quarter 2009 financial results conference call
...:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends
to release its second quarter and year end 2009 financial results on Wednesday, August 12, 2009 after the close of the U.S. and Canadian markets. Foll...
BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
...the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc. , is a chemical technology-based Life Science company that intends
to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organi...
Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
... 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends
that such forward-looking statements be subject to the safe harbors created thereby. Palatin's actual results may differ materially from those discuss...
Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia
Advanced Life Sciences intends
to comply with the Agency's recommendations and continue to pursue approval... satisfy the FDA's request for additional efficacy information. The Company intends
to meet with and work closely with the Agency to design and establish a pro...
Insmed to Host Second Quarter 2009 Conference Call
...d that it will host a conference call on Thursday, August 13(th), at 8:30 AM ET, to discuss its financial results for the second quarter 2009. Insmed intends
to issue its quarterly financial results press release before the market opens on August 13(th).
To participate in the live conference call, pl...
Intends in Biological Dictionary
...is. Brachial Plexus Injuries information sheet compiled by the National Institute of Neurological Disorders and Stroke (NINDS) This web site intends
to provide support, promote public awareness and serve as an invaluable resource for Brachial Plexus Neuromas, Erb's Palsy Nerve Injuries and ... ...